-
FerGene Appoints David Meek Chief Executive Officer
-FerGene, a new gene therapy company launched by Ferring Pharmaceuticals and Blackstone Life Sciences in November, today announced the appointment of David Meek as President and Chief Executive Officer …
0 -
FerGene announces pivotal Phase 3 study of nadofaragene firadenovec
-FerGene, a new gene therapy company formed by Ferring Pharmaceuticals and Blackstone Life Sciences, announced today positive results from the pivotal Phase 3 clinical trial evaluating nadofaragene firadenovec …
Archive for December, 2019
2019 > December